Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer-Reference-Cited by-同舟云学术

Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer

Published:2011-01-07 Issue:7 Volume:123 Page:1673-1677
ISSN:0044-8249
Container-title:Angewandte Chemie
language:de
Short-container-title:Angew. Chem.

Author:

Wilkinson Brendan L.,Day Stephanie,Malins Lara R.,Apostolopoulos Vasso,Payne Richard J.

Publisher

Wiley

Subject

General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ange.201006115/fullpdf

Reference52 articles.

1. Lewis blood group and CEA related antigens; coexpressed cell-cell adhesion molecules with roles in the biological progression and dissemination of tumours

2. MUC1 and cancer

3. Immunotherapy for cancer: synthetic carbohydrate-based vaccines

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conjugation of a Toll‐Like Receptor Agonist to Glycans of an HIV Native‐Like Envelope Trimer Preserves Neutralization Epitopes;ChemBioChem;2022-06-20

2. The Development of Vaccines from Synthetic Tumor‐Associated Mucin Glycopeptides and their Glycosylation‐Dependent Immune Response;The Chemical Record;2021-11

3. The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines;International Journal of Nanomedicine;2021-01

4. Fully synthetic Mincle-dependent self-adjuvanting cancer vaccines elicit robust humoral and T cell-dependent immune responses and protect mice from tumor development;Chemical Science;2021

5. Design, Synthesis, and Preliminary Immunological Studies of MUC1-Based Antitumor Vaccines Adjuvanted with R- and S-FSL-1;ACS Medicinal Chemistry Letters;2020-06-22